Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$319,894
+$15,801 QoQ
Shares Held
644
-5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#1,205
of 1,735 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEVEN MILE ADVISORY holds $349,916 across 2 Biotechnology names. VRTX ranks #1 (91.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
644 | $319,894 | |
| 2 | ALLO |
Allogene Therapeutics, Inc.
|
14,434 | $30,022 |
All Filings in VRTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $319,894 | 644 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $304,093 | 681 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $352,714 | 778 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $306,262 | 782 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $316,982 | 712 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $343,737 | 709 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $276,252 | 686 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $314,859 | 677 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $300,918 | 642 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $254,568 | 609 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $245,761 | 604 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $210,382 | 605 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $210,442 | 598 | Shares | Sole | 2023-08-08 | |
| No filing history on record for this holder in this stock. | ||||||